SCHEMBL2963586

SCHEMBL2963586

CN(C)c1cccc(NC(=O)c2ccc(Cl)c(NC(=O)c3ccc4ncccc4c3)c2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 2/20 0.57
MAPK14 Q16539 3/20 0.56
RAB9A P51151 5/20 0.53
NPC1 O15118 4/20 0.53
POLB P06746 1/20 0.53
BRAF P15056 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC2 Q92769 1/20 0.52
CASP3 P42574 1/20 0.51
SENP8 Q96LD8 1/20 0.51
SENP7 Q9BQF6 1/20 0.51
SENP6 Q9GZR1 1/20 0.51
HTT P42858 1/20 0.50
PABPC1 P11940 1/20 0.50
PLK1 P53350 1/20 0.50
HSF1 Q00613 1/20 0.50
SIRT1 Q96EB6 1/20 0.48
DOT1L Q8TEK3 1/20 0.48
EGFR P00533 2/20 0.47
MAPT P10636 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2978412 0.89 CSF1R (0.70) CSF1RMAPK14RAB9ANPC1POLB
SCHEMBL7611676 0.88 RAB9A (0.61) CSF1RRAB9ANPC1POLBBRAF
SCHEMBL5897023 0.82 PABPC1 (0.72) CSF1RRAB9ANPC1POLBBRAF
SCHEMBL5897487 0.82 CSF1R (0.81) CSF1RMAPK14RAB9ANPC1POLB
SCHEMBL2976951 0.82 HDAC1 (0.61) RAB9ANPC1POLBBRAFHDAC1
SCHEMBL27509830 0.82 HDAC1 (0.61) RAB9ANPC1POLBBRAFHDAC1
SCHEMBL7853417 0.81 CSF1R (0.68) CSF1RMAPK14RAB9ANPC1POLB
SCHEMBL2979486 0.81 ALOX15 (0.70) RAB9ANPC1POLBHDAC1HDAC2
Hydrochloric Acid SCHEMBL2974700 0.81 HDAC1 (0.60) RAB9ANPC1POLBBRAFHDAC1
SCHEMBL5897360 0.78 PABPC1 (0.56) CSF1RRAB9ANPC1POLBBRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7772432-B2 Amidobenzamide derivatives which are useful as cytokine inhibitors ASTRAZENECA AB (SE) 2010-08-10 US claimed
CN-1243724-C Amide derivatives which are useful as cell factor inhibitors ASTRA ZENECA LTD (SE) 2006-03-01 CN claimed
US-20050038081-A1 Amidobenzamide derivatives which are useful as cytokine inhibitors ASTRAZENECA 2005-02-17 US claimed
CN-1330631-A Amide derivatives which are useful as cell factor inhibitors ASTRA ZENECA LTD (SE) 2002-01-09 CN claimed
EP-1102743-A1 AMIDE DERIVATIVES WHICH ARE USEFUL AS CYTOKINE INHIBITORS AstraZeneca AB (SE) 2001-05-30 EP claimed
WO-2000007980-A1 AMIDE DERIVATIVES WHICH ARE USEFUL AS CYTOKINE INHIBITORS ASTRAZENECA AB (SE) 2000-02-17 WO claimed
US-7772432-B2 Amidobenzamide derivatives which are useful as cytokine inhibitors ASTRAZENECA AB (SE) 2010-08-10 US disclosed
CN-1243724-C Amide derivatives which are useful as cell factor inhibitors ASTRA ZENECA LTD (SE) 2006-03-01 CN disclosed
US-20050038081-A1 Amidobenzamide derivatives which are useful as cytokine inhibitors ASTRAZENECA 2005-02-17 US disclosed
US-6821965-B1 IMPORTANT IN DISEASE OR MEDICAL CONDITIONS SUCH AS INFLAMMATION AND IMMUNOREGULATION ASTERZENECA AB (SE) 2004-11-23 US disclosed
CN-1330631-A Amide derivatives which are useful as cell factor inhibitors ASTRA ZENECA LTD (SE) 2002-01-09 CN disclosed
EP-1102743-A1 AMIDE DERIVATIVES WHICH ARE USEFUL AS CYTOKINE INHIBITORS AstraZeneca AB (SE) 2001-05-30 EP disclosed
WO-2000007980-A1 AMIDE DERIVATIVES WHICH ARE USEFUL AS CYTOKINE INHIBITORS ASTRAZENECA AB (SE) 2000-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038081-A1 Amidobenzamide derivatives which are useful as cytokine inhibitors IL6, IL6ST, IL2 CSF1R 350/4885MAPK14 1775/4885RAB9A 1437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.